Condensed Consolidated Statements of Stockholders' Deficit - USD ($) $ in Thousands |
Total |
Class A Common Stock |
Class B Common Stock |
Common Stock
Class A Common Stock
|
Common Stock
Class B Common Stock
|
Additional Paid-in Capital |
Accumulated Other Comprehensive Income (Loss) |
Accumulated Deficit |
Stockholders (deficit) equity, beginning balance (shares) at Jan. 31, 2021 |
|
|
|
3,263,659
|
27,271,435
|
|
|
|
Stockholders (deficit) equity, beginning balance at Jan. 31, 2021 |
$ (83,459)
|
|
|
$ 3
|
$ 27
|
$ 1,038,006
|
$ 877
|
$ (1,122,372)
|
Increase (Decrease) in Stockholders' Equity (Deficit) [Roll Forward] |
|
|
|
|
|
|
|
|
Vesting of restricted stock units (shares) |
|
|
|
|
703,571
|
|
|
|
Vesting of restricted stock units |
1
|
|
|
|
$ 1
|
|
|
|
Shares repurchased for tax withholdings on vesting of restricted stock (shares) |
|
|
|
|
(94,435)
|
|
|
|
Shares repurchased for tax withholdings on vesting of restricted stock |
(6,244)
|
|
|
|
|
(6,244)
|
|
|
Issuance of common stock under employee stock purchase plan (shares) |
|
|
|
|
505,020
|
|
|
|
Issuance of common stock under employee stock purchase plan |
4,133
|
|
|
|
|
4,133
|
|
|
Exercise of stock options (shares) |
|
|
|
|
31,188
|
|
|
|
Exercise of stock options |
654
|
|
|
|
|
654
|
|
|
Stock-based compensation expense |
10,074
|
|
|
|
|
10,074
|
|
|
Other comprehensive income (loss) |
(4)
|
|
|
|
|
|
(4)
|
|
Net loss |
(18,104)
|
|
|
|
|
|
|
(18,104)
|
Stockholders (deficit) equity, ending balance (shares) at Apr. 30, 2021 |
|
|
|
3,263,659
|
28,416,779
|
|
|
|
Stockholders (deficit) equity, ending balance at Apr. 30, 2021 |
(92,949)
|
|
|
$ 3
|
$ 28
|
1,046,623
|
873
|
(1,140,476)
|
Stockholders (deficit) equity, beginning balance (shares) at Jan. 31, 2021 |
|
|
|
3,263,659
|
27,271,435
|
|
|
|
Stockholders (deficit) equity, beginning balance at Jan. 31, 2021 |
(83,459)
|
|
|
$ 3
|
$ 27
|
1,038,006
|
877
|
(1,122,372)
|
Increase (Decrease) in Stockholders' Equity (Deficit) [Roll Forward] |
|
|
|
|
|
|
|
|
Net loss |
(68,857)
|
$ (7,077)
|
$ (61,780)
|
|
|
|
|
|
Stockholders (deficit) equity, ending balance (shares) at Oct. 31, 2021 |
|
|
|
3,263,659
|
29,345,776
|
|
|
|
Stockholders (deficit) equity, ending balance at Oct. 31, 2021 |
(112,557)
|
|
|
$ 3
|
$ 29
|
1,077,993
|
647
|
(1,191,229)
|
Stockholders (deficit) equity, beginning balance (shares) at Apr. 30, 2021 |
|
|
|
3,263,659
|
28,416,779
|
|
|
|
Stockholders (deficit) equity, beginning balance at Apr. 30, 2021 |
(92,949)
|
|
|
$ 3
|
$ 28
|
1,046,623
|
873
|
(1,140,476)
|
Increase (Decrease) in Stockholders' Equity (Deficit) [Roll Forward] |
|
|
|
|
|
|
|
|
Vesting of restricted stock units (shares) |
|
|
|
|
286,617
|
|
|
|
Vesting of restricted stock units |
1
|
|
|
|
$ 1
|
|
|
|
Shares repurchased for tax withholdings on vesting of restricted stock (shares) |
|
|
|
|
(16,612)
|
|
|
|
Shares repurchased for tax withholdings on vesting of restricted stock |
(1,334)
|
|
|
|
|
(1,334)
|
|
|
Exercise of stock options (shares) |
|
|
|
|
107,804
|
|
|
|
Exercise of stock options |
2,509
|
|
|
|
|
2,509
|
|
|
Stock-based compensation expense |
12,621
|
|
|
|
|
12,621
|
|
|
Exercise of common stock warrants (shares) |
|
|
|
|
100,000
|
|
|
|
Other comprehensive income (loss) |
(146)
|
|
|
|
|
|
(146)
|
|
Net loss |
(22,240)
|
|
|
|
|
|
|
(22,240)
|
Stockholders (deficit) equity, ending balance (shares) at Jul. 31, 2021 |
|
|
|
3,263,659
|
28,894,588
|
|
|
|
Stockholders (deficit) equity, ending balance at Jul. 31, 2021 |
(101,538)
|
|
|
$ 3
|
$ 29
|
1,060,419
|
727
|
(1,162,716)
|
Increase (Decrease) in Stockholders' Equity (Deficit) [Roll Forward] |
|
|
|
|
|
|
|
|
Vesting of restricted stock units (shares) |
|
|
|
|
363,635
|
|
|
|
Vesting of restricted stock units |
0
|
|
|
|
$ 0
|
|
|
|
Shares repurchased for tax withholdings on vesting of restricted stock (shares) |
|
|
|
|
(16,613)
|
|
|
|
Shares repurchased for tax withholdings on vesting of restricted stock |
(1,280)
|
|
|
|
|
(1,280)
|
|
|
Exercise of stock options (shares) |
|
|
|
|
104,166
|
|
|
|
Exercise of stock options |
745
|
|
|
|
|
745
|
|
|
Stock-based compensation expense |
18,109
|
|
|
|
|
18,109
|
|
|
Other comprehensive income (loss) |
(80)
|
|
|
|
|
|
(80)
|
|
Net loss |
(28,513)
|
$ (2,876)
|
$ (25,637)
|
|
|
|
|
(28,513)
|
Stockholders (deficit) equity, ending balance (shares) at Oct. 31, 2021 |
|
|
|
3,263,659
|
29,345,776
|
|
|
|
Stockholders (deficit) equity, ending balance at Oct. 31, 2021 |
(112,557)
|
|
|
$ 3
|
$ 29
|
1,077,993
|
647
|
(1,191,229)
|
Stockholders (deficit) equity, beginning balance (shares) at Jan. 31, 2022 |
|
3,263,659
|
29,729,822
|
3,263,659
|
29,729,822
|
|
|
|
Stockholders (deficit) equity, beginning balance at Jan. 31, 2022 |
(125,978)
|
|
|
$ 3
|
$ 30
|
1,098,084
|
388
|
(1,224,483)
|
Increase (Decrease) in Stockholders' Equity (Deficit) [Roll Forward] |
|
|
|
|
|
|
|
|
Vesting of restricted stock units (shares) |
|
|
|
|
527,423
|
|
|
|
Issuance of common stock under employee stock purchase plan (shares) |
|
|
|
|
164,959
|
|
|
|
Issuance of common stock under employee stock purchase plan |
1,563
|
|
|
|
|
1,563
|
|
|
Exercise of stock options (shares) |
|
|
|
|
37,727
|
|
|
|
Exercise of stock options |
724
|
|
|
|
|
724
|
|
|
Stock-based compensation expense |
25,328
|
|
|
|
|
25,328
|
|
|
Other comprehensive income (loss) |
(703)
|
|
|
|
|
|
(703)
|
|
Net loss |
(32,888)
|
|
|
|
|
|
|
(32,888)
|
Stockholders (deficit) equity, ending balance (shares) at Apr. 30, 2022 |
|
|
|
3,263,659
|
30,459,931
|
|
|
|
Stockholders (deficit) equity, ending balance at Apr. 30, 2022 |
(131,954)
|
|
|
$ 3
|
$ 30
|
1,125,699
|
(315)
|
(1,257,371)
|
Stockholders (deficit) equity, beginning balance (shares) at Jan. 31, 2022 |
|
3,263,659
|
29,729,822
|
3,263,659
|
29,729,822
|
|
|
|
Stockholders (deficit) equity, beginning balance at Jan. 31, 2022 |
$ (125,978)
|
|
|
$ 3
|
$ 30
|
1,098,084
|
388
|
(1,224,483)
|
Increase (Decrease) in Stockholders' Equity (Deficit) [Roll Forward] |
|
|
|
|
|
|
|
|
Exercise of stock options (shares) |
47,389
|
|
|
|
|
|
|
|
Net loss |
$ (85,738)
|
$ (8,257)
|
$ (77,481)
|
|
|
|
|
|
Stockholders (deficit) equity, ending balance (shares) at Oct. 31, 2022 |
|
3,263,659
|
31,281,307
|
3,263,659
|
31,281,307
|
|
|
|
Stockholders (deficit) equity, ending balance at Oct. 31, 2022 |
(146,125)
|
|
|
$ 3
|
$ 31
|
1,165,522
|
(1,460)
|
(1,310,221)
|
Stockholders (deficit) equity, beginning balance (shares) at Apr. 30, 2022 |
|
|
|
3,263,659
|
30,459,931
|
|
|
|
Stockholders (deficit) equity, beginning balance at Apr. 30, 2022 |
(131,954)
|
|
|
$ 3
|
$ 30
|
1,125,699
|
(315)
|
(1,257,371)
|
Increase (Decrease) in Stockholders' Equity (Deficit) [Roll Forward] |
|
|
|
|
|
|
|
|
Vesting of restricted stock units (shares) |
|
|
|
|
533,234
|
|
|
|
Vesting of restricted stock units |
1
|
|
|
|
$ 1
|
|
|
|
Exercise of stock options (shares) |
|
|
|
|
4,605
|
|
|
|
Exercise of stock options |
81
|
|
|
|
|
81
|
|
|
Stock-based compensation expense |
20,451
|
|
|
|
|
20,451
|
|
|
Other comprehensive income (loss) |
(386)
|
|
|
|
|
|
(386)
|
|
Net loss |
(29,139)
|
|
|
|
|
|
|
(29,139)
|
Stockholders (deficit) equity, ending balance (shares) at Jul. 31, 2022 |
|
|
|
3,263,659
|
30,997,770
|
|
|
|
Stockholders (deficit) equity, ending balance at Jul. 31, 2022 |
(140,946)
|
|
|
$ 3
|
$ 31
|
1,146,231
|
(701)
|
(1,286,510)
|
Increase (Decrease) in Stockholders' Equity (Deficit) [Roll Forward] |
|
|
|
|
|
|
|
|
Vesting of restricted stock units (shares) |
|
|
|
|
278,480
|
|
|
|
Exercise of stock options (shares) |
|
|
|
|
5,057
|
|
|
|
Exercise of stock options |
56
|
|
|
|
|
56
|
|
|
Stock-based compensation expense |
19,235
|
|
|
|
|
19,235
|
|
|
Other comprehensive income (loss) |
(759)
|
|
|
|
|
|
(759)
|
|
Net loss |
(23,711)
|
$ (2,250)
|
$ (21,461)
|
|
|
|
|
(23,711)
|
Stockholders (deficit) equity, ending balance (shares) at Oct. 31, 2022 |
|
3,263,659
|
31,281,307
|
3,263,659
|
31,281,307
|
|
|
|
Stockholders (deficit) equity, ending balance at Oct. 31, 2022 |
$ (146,125)
|
|
|
$ 3
|
$ 31
|
$ 1,165,522
|
$ (1,460)
|
$ (1,310,221)
|